SpineGuard SA announced a private placement of 500,000 common shares at an issue price of â¬1 per share for the gross proceeds of â¬500,000 on May 16, 2023. The transaction included participation from new investor SuZhou Xinrong Best Medical Instrument Co., Ltd representing 1.28% stake of current issued shares. The shares are restricted to a hold period of 18 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2235 EUR | -2.83% | -6.29% | +11.97% |
Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+11.97% | 11.32M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.01B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard SA announced that it has received €0.5 million in funding from SuZhou Xinrong Best Medical Instrument Co., Ltd